• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virology . Influenza D virus Matrix protein 1 restricts the type I interferon response by degrading TRAF6

tetano

Editor, Senior Moderator
Virology


. 2022 Jan 13;568:1-11.
doi: 10.1016/j.virol.2022.01.001. Online ahead of print.
Influenza D virus Matrix protein 1 restricts the type I interferon response by degrading TRAF6


Zhaoshan Chen[SUP] 1 [/SUP], Yan Zeng[SUP] 1 [/SUP], Yanli Wei[SUP] 1 [/SUP], Qian Wang[SUP] 1 [/SUP], Minxuan Liu[SUP] 1 [/SUP], Bo Zhang[SUP] 1 [/SUP], Junwen Liu[SUP] 1 [/SUP], Qiyun Zhu[SUP] 2 [/SUP], Shuai Xu[SUP] 3 [/SUP]



Affiliations

Abstract

Influenza D virus (IDV) is an emerged virus that was first isolated in 2011 in the United States. Evidence suggests that IDV has broad host tropism and zoonotic potential. However, the immune evasion mechanism of IDV has not been explored. In the present study, we identified that the Matrix protein 1 (M1) of IDV is a negative regulator of virus- or RIG-IN-triggered type I interferon induction. Co-immunoprecipitation experiments revealed that M1 specifically interacts with tumor necrosis factor receptor associated factor 6 (TRAF6) and potentiates its proteasomal degradation by promoting K48-linked polyubiquitination. Moreover, we discovered that E3 ubiquitin ligase KEAP1 is recruited by M1 to catalyze K48-linked polyubiquitination of TRAF6, and promotes TRAF6 destabilization. Consequently, the degradation cascade mediated by M1 blocks RIG-I-TRAF6 mediated interferon signaling. Taken together, our findings reveal a negative regulatory role for the IDV M1 in the type І interferon pathway.

Keywords: Influenza D virus; Innate immunity; KEAP1; Matrix protein 1; TRAF6.
 
Back
Top Bottom